Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR — S-PRP  

Severe Non-proliferative Diabetic Retinopathy Clinical Trial

Official title: Randomized, Parallel Controlled, Clinical-trial on 532nm Laser Partially Subthreshold Panretinal Photocoagulation With PASCAL Endpoint Management Function for Severe Non-proliferative Diabetic Retinopathy(NPDR)

Status Recruiting

Clinical Trial Summary

This randomized, parallel controlled, clinical-trial aims to evaluate the therapeutic efficacy of 532nm laser partially subthreshold panretinal photocoagulation with PASCAL endpoint management function for severe non-proliferative diabetic retinopathy.

Clinical Trial Description

This randomized, parallel controlled, clinical-trial aims to evaluate the therapeutic efficacy of 532nm laser partially subthreshold panretinal photocoagulation with PASCAL endpoint management function for severe non-proliferative diabetic retinopathy : (1)To evaluate therapeutic effect of 532nm laser partially subthreshold panretinal photocoagulation with PASCAL endpoint management function for severe non-proliferative diabetic retinopathy; (2)To compare side effect of 532nm laser partially subthreshold panretinal photocoagulation with PASCAL endpoint management function on retina with traditional visible endpoint panretinal photocoagulation. ;

Related Conditions & MeSH terms

• Diabetic Retinopathy
• Retinal Diseases
• Severe Non-proliferative Diabetic Retinopathy

• NCT number: NCT01759121
• Study type: Interventional
• Source: Sun Yat-sen University
• Contact: Pei-pei Wu
• Phone: 13602457876
• Email: ree04@126.com
• Status: Recruiting
• Phase: N/A
• Start date: March 2016
• Completion date: December 2018